Mark Baxter

So I can talk a little bit about what it looks like on the ground and how that's working and what we're seeing.

Yeah, and this is like, they're new and emerging treatments, but just to give a bit of context, MDMA-assisted therapy, the clinical trials in that area, mostly in America, but also around the world, have been in play since the very early 2000s.

So it's like about 25 years of

clinical trial experience and research outcomes there and for psilocybin assisted therapy so psilocybin is kind of like one of the active ingredients in magic mushrooms people have been using that from the late 50s through the 60s in the early 70s there was a lot of research in that area so there was up to 40 000 research participants you know across that area and then that research got shut down in the early 70s by the american government for different political reasons and

So all of that research was kind of put on hold.

And it wasn't until the late 90s and the early 2000s where people started to kind of get the licenses to kind of research this again.

So it's kind of new and emerging in a way, but it's kind of actually not so new and emerging in a larger context.

Yeah, and also psilocybin mushrooms have been used by different indigenous cultures for hundreds and maybe thousands of years.

There's different kind of archaeological evidence for the use in different parts of the world.

So this is not a new thing in human culture.

The MDMA-assisted therapy was used a lot for couples therapy in the 70s and the early 80s.

It wasn't made illegal until about 1985 in America.

So there was a period of time there where it was being used by therapists for those indications.

And then that therapy had to go underground at that stage after it was made illegal in 1985.

And so it's only been again since the early 2000s that that's come out in more research.

So just a bit of the history, I guess.

So we're not doing things that are totally experimental.

We're kind of riding on the back of lots of clinical trial work at the moment.

No, Australia is the world leader.

So we're the only country in the world that can offer MDMA-assisted therapy in a clinical context.